Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
Clinical trial NCT03062540 · TERMINATED
Trial details
- NCT number
- NCT03062540
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-27
- Primary completion
- 2018-07-27
- Enrollment
- 358
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.